Genta reports Tesetaxel Phase 2b trial data
Tesetaxel is a novel, orally absorbed taxane that has been evaluated in a completed or ongoing Phase 2a/Phase 2b clinical trials. The Phase 2b study enrolled 41 gastric
Isomorphic Labs has raised $5bn in a Series C financing round to support the development of its AI platform and advance its therapeutic candidates towards clinical evaluation.